Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF Neutralization
Giorgia Nardo(Johannes Gutenberg University Mainz), Stefano Indraccolo(University of Padua), Elisabetta Zulato, Rossella Canese(Istituto Superiore di Sanità), Matteo Curtarello(Johannes Gutenberg University Mainz), Lidia Moserle(Institut d'Investigació Biomédica de Bellvitge), Elena Favaro(Genmab (Denmark)), Ulrike Sattler(Johannes Gutenberg University Mainz), Elisabetta Rossi(Johannes Gutenberg University Mainz), Oriol Casanovas(Institut Català d'Oncologia), Luca Persano(University of Padua), Egidio Iorio(Johannes Gutenberg University Mainz), Marika Crescenzi(Johannes Gutenberg University Mainz), Giovanni Esposito(Johannes Gutenberg University Mainz), Oliver Thews(University Hospital in Halle), Alberto Amadori(University of Padua), Barbara Biesalski(Johannes Gutenberg University Mainz), Wolfgang Mueller‐Klieser(Johannes Gutenberg University Mainz), Paola Zanovello(University of Padua)
Cited by 74
Related Papers
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
|Cancer Cell|2009|2.3k
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
|Cancer Cell|2005|1.6k
Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF–VEGFR2 signalling
|Nature|2012|365
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
|Oncotarget|2014|288
Unraveling the Role of Angiogenesis in Cancer Ecosystems
|Frontiers in Oncology|2018|275